Astrazeneca Pharma
-
{
- All
- News
-
Cancer Drug Imfinzi Gets Indian Regulator's Approval For Use In First-Line Treatment
- Tuesday February 10, 2026
- Health | Indo-Asian News Service
AstraZeneca Pharma India Limited on Tuesday said it has received permission from the Central Drugs Standard Control Organisation to sell and distribute Durvalumab solution for infusion used in cancer treatment.
-
www.ndtv.com
-
AstraZeneca Pharma's Cancer-Treating Drug Gets Regulator's Nod In India
- Wednesday May 3, 2023
- India News | Press Trust of India
AstraZeneca Pharma India Ltd on Wednesday said it has received an approval from the Drug Controller General of India (DCGI) for the cancer drug trastuzumab deruxtecan for treatment of metastatic breast cancer.
-
www.ndtv.com
-
Cancer Drug Imfinzi Gets Indian Regulator's Approval For Use In First-Line Treatment
- Tuesday February 10, 2026
- Health | Indo-Asian News Service
AstraZeneca Pharma India Limited on Tuesday said it has received permission from the Central Drugs Standard Control Organisation to sell and distribute Durvalumab solution for infusion used in cancer treatment.
-
www.ndtv.com
-
AstraZeneca Pharma's Cancer-Treating Drug Gets Regulator's Nod In India
- Wednesday May 3, 2023
- India News | Press Trust of India
AstraZeneca Pharma India Ltd on Wednesday said it has received an approval from the Drug Controller General of India (DCGI) for the cancer drug trastuzumab deruxtecan for treatment of metastatic breast cancer.
-
www.ndtv.com